Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation

AimsSeveral models have been developed to predict the risk of atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA). However, these models are of poor quality from the start. We, therefore, aimed to develop and validate a predictive model for post-operative recurrence of...

Full description

Bibliographic Details
Main Authors: Guangling Li, Xiaomei Wang, Jing-jing Han, Xueya Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042573/full
_version_ 1797987590031278080
author Guangling Li
Xiaomei Wang
Jing-jing Han
Xueya Guo
author_facet Guangling Li
Xiaomei Wang
Jing-jing Han
Xueya Guo
author_sort Guangling Li
collection DOAJ
description AimsSeveral models have been developed to predict the risk of atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA). However, these models are of poor quality from the start. We, therefore, aimed to develop and validate a predictive model for post-operative recurrence of AF.Materials and methodsIn a study including 433 patients undergoing the first circumferential pulmonary vein isolation (CPVI) procedure, independent predictors of AF recurrence were retrospectively identified. Using the Cox regression of designated variables, a risk model was developed in a random sample of 70% of the patients (development cohort) and validated in the remaining (validation cohort) 30%. The accuracy and discriminative power of the predictive models were evaluated in both cohorts.ResultsDuring the established 12 months follow-up, 134 patients (31%) recurred. Six variables were identified in the model including age, coronary artery disease (CAD), heart failure (HF), hypertension, transient ischemic attack (TIA) or cerebrovascular accident (CVA), and left atrial diameter (LAD). The model showed good discriminative power in the development cohort, with an AUC of 0.77 (95% confidence interval [CI], 0.69–0.86). Furthermore, the model shows good agreement between actual and predicted probabilities in the calibration curve. The above results were confirmed in the validation cohort. Meanwhile, decision curve analysis (DCA) for this model also demonstrates the advantages of clinical application.ConclusionA simple risk model to predict AF recurrence after ablation was developed and validated, showing good discriminative power and calibration.
first_indexed 2024-04-11T07:49:25Z
format Article
id doaj.art-5d01f5937d734d4fbdef4089d5122d63
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T07:49:25Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-5d01f5937d734d4fbdef4089d5122d632022-12-22T04:36:08ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-12-01910.3389/fcvm.2022.10425731042573Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablationGuangling Li0Xiaomei Wang1Jing-jing Han2Xueya Guo3Lanzhou University Second Hospital, The Second Clinical Medical College of Lanzhou University, Lanzhou, ChinaLanzhou University Second Hospital, The Second Clinical Medical College of Lanzhou University, Lanzhou, ChinaDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, ChinaDepartment of Cardiology, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, ChinaAimsSeveral models have been developed to predict the risk of atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA). However, these models are of poor quality from the start. We, therefore, aimed to develop and validate a predictive model for post-operative recurrence of AF.Materials and methodsIn a study including 433 patients undergoing the first circumferential pulmonary vein isolation (CPVI) procedure, independent predictors of AF recurrence were retrospectively identified. Using the Cox regression of designated variables, a risk model was developed in a random sample of 70% of the patients (development cohort) and validated in the remaining (validation cohort) 30%. The accuracy and discriminative power of the predictive models were evaluated in both cohorts.ResultsDuring the established 12 months follow-up, 134 patients (31%) recurred. Six variables were identified in the model including age, coronary artery disease (CAD), heart failure (HF), hypertension, transient ischemic attack (TIA) or cerebrovascular accident (CVA), and left atrial diameter (LAD). The model showed good discriminative power in the development cohort, with an AUC of 0.77 (95% confidence interval [CI], 0.69–0.86). Furthermore, the model shows good agreement between actual and predicted probabilities in the calibration curve. The above results were confirmed in the validation cohort. Meanwhile, decision curve analysis (DCA) for this model also demonstrates the advantages of clinical application.ConclusionA simple risk model to predict AF recurrence after ablation was developed and validated, showing good discriminative power and calibration.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042573/fullatrial fibrillationradiofrequency catheter ablationatrial fibrillation recurrenceprediction modelrecurrence risk
spellingShingle Guangling Li
Xiaomei Wang
Jing-jing Han
Xueya Guo
Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
Frontiers in Cardiovascular Medicine
atrial fibrillation
radiofrequency catheter ablation
atrial fibrillation recurrence
prediction model
recurrence risk
title Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
title_full Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
title_fullStr Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
title_full_unstemmed Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
title_short Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
title_sort development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
topic atrial fibrillation
radiofrequency catheter ablation
atrial fibrillation recurrence
prediction model
recurrence risk
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042573/full
work_keys_str_mv AT guanglingli developmentandvalidationofanovelriskmodelforpredictingatrialfibrillationrecurrenceriskamongparoxysmalatrialfibrillationpatientsafterthefirstcatheterablation
AT xiaomeiwang developmentandvalidationofanovelriskmodelforpredictingatrialfibrillationrecurrenceriskamongparoxysmalatrialfibrillationpatientsafterthefirstcatheterablation
AT jingjinghan developmentandvalidationofanovelriskmodelforpredictingatrialfibrillationrecurrenceriskamongparoxysmalatrialfibrillationpatientsafterthefirstcatheterablation
AT xueyaguo developmentandvalidationofanovelriskmodelforpredictingatrialfibrillationrecurrenceriskamongparoxysmalatrialfibrillationpatientsafterthefirstcatheterablation